Rhinitis/Nasal Polyps
Most dupilumab use for asthma, CRSwNP categorized as persistent
Researchers characterized the use of dupilumab among a cohort of patients with asthma, chronic rhinosinusitis with nasal polyps or both as persistent in a study published in Annals of Allergy, Asthma & Immunology.
Speaker: Current biomarkers in asthma care lack stability
ANAHEIM, Calif. — Better biomarkers for diagnosis and prognosis are needed for better personalized asthma care, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Dupilumab improves sleep among patients with chronic rhinosinusitis with nasal polyps
Sleep improved for patients with chronic rhinosinusitis with nasal polyps after a month of treatment with dupilumab, according to a study published in Annals of Allergy, Asthma & Immunology.
Symptom patterns emerge in NSAID-exacerbated respiratory disease development
Age, sex, ethnicity, BMI and environmental exposures were associated with different patterns in NSAID-exacerbated respiratory disease development, according to a study in The Journal of Allergy and Clinical Immunology: In Practice.
Protective gel from nasal spray reduces seasonal allergic rhinitis symptoms
Designed for over-the-counter use, the Bentrio nasal spray from Altamira Therapeutics was more effective in treating nasal symptoms in seasonal allergic rhinitis than saline solution, according to a press release from the company.
Parameters guide treatment for chronic rhinosinusitis with nasal polyps
The Allergy-Immunology Joint Task Force on Practice Parameters has issued guidelines for the medical management of chronic rhinosinusitis with nasal polyps, according to a review published in Annals of Allergy, Asthma & Immunology.